One of several spinal muscular atrophies associated with defects in the human gene SMN1. See human disease model report for spinal muscular atrophy, SMN-related (FBhh0000352).
Variant(s) implicated in human disease tested (as analogous mutation in fly gene): F70S in in the fly Smn gene (corresponds to W92S in the human SMN1 gene, implicated in SMA1); I93F in in the fly Smn gene (corresponds to I116F in the human SMN1 gene, implicated in SMA1); M194R in in the fly Smn gene (corresponds to M263R in the human SMN1 gene, implicated in SMA1); Y203C in in the fly Smn gene (corresponds to Y272C in the human SMN1 gene, implicated primarily in SMA1); G210V in in the fly Smn gene (corresponds to G279V in the human SMN1 gene, implicated in SMA1).
[updated Apr. 2019 by FlyBase; FBrf0222196]
Spinal muscular atrophy (SMA) is characterized by progressive muscle weakness resulting from degeneration and loss of the anterior horn cells (i.e., lower motor neurons) in the spinal cord and the brain stem nuclei. Onset ranges from before birth to adolescence or young adulthood. Poor weight gain, sleep difficulties, pneumonia, scoliosis, and joint contractures are common complications. [From GeneReviews, Spinal Muscular Atrophy, pubmed:20301526 2016.07.11]
[SPINAL MUSCULAR ATROPHY, TYPE I; SMA1](https://omim.org/entry/253300)
[SURVIVAL OF MOTOR NEURON 1; SMN1](https://omim.org/entry/600354)
Many to one: 2 human to 1 Drosophila.
Ortholog of human SMN and SMN2 (1 Drosophila to 1 human). Dmel\Smn shares 26% identity and 42% similarity with human SMN1 and 26% identity and 42% similarity with human SMN2.